Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemoimmunotherapy for Colorectal Cancer
NCT00003063Phase 3Unknown
- Sponsor
- European Institute of Oncology
- Start
- Nov 1991
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised trial of levamisole and interferon alfa in colorectal cancer (CRC) (3 arms), sponsored by European Institute of Oncology. Primary endpoints: Efficacy of adjuvant treatment and Disease-Free Survival at 5 years. Status: unknown.
02
Drugs
levamisoleinterferon alfa
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003063.